{
  "trial_id": "NCT04316494",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Age",
      "label": "met",
      "evidence": "57 years old"
    },
    {
      "criterion": "Diagnosis of Granulomatosis Polyangiitis (GPA)",
      "label": "met",
      "evidence": "Wegener's granulomatosis was diagnosed for him"
    },
    {
      "criterion": "Birmingham Vasculitis Activity Score >3 (BVAS v.3)",
      "label": "met",
      "evidence": "His Birmingham Vasculitis Activity Score (BVAS) is above 4 since the beginning of his disease"
    },
    {
      "criterion": "Maintenance therapy for 4 weeks prior to randomisation",
      "label": "met",
      "evidence": "He is treating with corticosteroid and cyclophosphamides since 4 months ago"
    },
    {
      "criterion": "Female patient eligibility",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "No contraindications to hydroxychloroquine therapy",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Normal baseline visual fields at screening",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Willing and able to give written informed consent",
      "label": "met",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "Patients currently taking hydroxychloroquine or related antimalarial",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Estimated glomerular filtration rate (eGFR) <30 ml/min",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Patients weighing <40kg",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Sensitivity, anaphylaxis or allergy to hydroxychloroquine or any other 4-aminoquinoline compound",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Known glucose 6 phosphate dehydrogenase deficiency",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Known lactose intolerance",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Evidence of plaque psoriasis",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Concomitant use of tumour necrosis factor inhibitor treatment (e.g. etanercept)",
      "label": "not_met",
      "evidence": ""
    }
  ],
  "notes": "",
  "_meta": {
    "topic_id": "54",
    "trial_id": "NCT04316494",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}